Research Institute for Sport & Exercise Sciences
Liverpool, United Kingdom
NCT Number: NCT04370353
In recent years, there has been significant interest in dietary flavonoids (biologically active plant-derived compounds) as potential therapeutics. This is due to the capacity of flavonoids to enhance processes related to energy metabolism and cardiovascular health. We are interested in implementing a short-term supplementation regime (daily cocoa-flavanoid ingestion), in order to explore the possible beneficial effects of flavonoid-based interventions on responses to exercise. Hence, the objective of our study is to examine the impact of short term cocoa-flavanoid supplementation on processes related to energy use (oxygen utilisation). Our aim is to develop a novel intervention which improves cardiovascular health and enhances exercise tolerance.
Looking for future studies?
Notify Me35 year–55 year
All sexes
Interventional
Not applicable
Liverpool, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Flavonoid-rich cocoa powder, containing 100mg total flavanols per 316mg.
Microcrystalline filler, containing 0mg total flavanols.
Time frame: Over 3 week period (After 7 days of each intervention). Oxygen uptake measured for 9 minutes continuously during exercise bouts (3 min warm up period and 6 minutes of exercise transition)
Oxygen uptake kinetics (including time constant, time delay and amplitude of the fundamental oxygen uptake response) will be determined by modelling oxygen uptake during exercise using a mono exponential function. The oxygen uptake data is measured on a breath-by-breath basis during exercise (on a cycle ergometer) using a gas analysis system and face mask. Oxygen kinetics will be measured during three moderate-intensity step exercise tests (at 80% of the gas exchange threshold) and during one severe-intensity (60%∆) step exercise test that is completed to failure.
Time frame: Over 3 week period (After 7 days of each intervention).
Participants capacity to exercise to the limit of tolerance, measured to the nearest second. Participants are instructed to exercise at a severe-intensity exercise load (representative of 60% ∆), on a cycle ergometer until volitional exhaustion.
Time frame: Over 3 week period (After 7 days of each intervention). Measured during the length of each exercise transition (9 minutes for each moderate intensity bout).
Heart rate will be measured during moderate and severe-intensity exercise bouts, by short-range telemetry.
Time frame: Over 3 week period (After 7 days of each intervention). Measured over 5 minutes before any exercise testing.
Systolic and diastolic blood pressure will be assessed following 10 min of seated rest using an automated sphygmomanometer
Time frame: Over 3 week period (After 7 days of each intervention). Measured immediately before and after exercise
A finger prick blood sample will be taken to measure blood lactate pre- and post-exercise of each transition using a hand-held automated blood lactate analyser
Time frame: Over 3 week period (In the 6 days preceding experimental testing)
Physical activity levels will be assessed in the 6 days prior to visiting the laboratory by an accelerometer, worn on the hip during waking hours.
Time frame: Over 3 week period (After 7 days of each intervention). Measured immediately before and after exercise
Perceived mental workload will be measured pre and post exercise using NASA Task Load Index and BORG rating of perceived exertion scale.
Liverpool John Moores University
Other
Investigating the Impact of Cocoa Flavanol Supplementation on Pulmonary Oxygen Uptake Kinetics and Exercise Tolerance in Sedentary Middle-aged Adults
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04592614
Aging, Behavior
Vancouver, British Columbia, Canada
View Trial DetailsNCT04136938
Aging, Behavior
Saint-Etienne, France
View Trial DetailsNCT06018974
Aging, Behavior
Oulu, Finland
View Trial DetailsNCT04134585
Aging, Behavior
Saint-Etienne, France
View Trial Details